Ethyl eicosapentaenoate (EPA) for Depression
This study is recruiting in the United Kingdom. It is testing ethyl eicosapentaenoate (EPA) for Depression.
In United Kingdom
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United Kingdom. It is testing ethyl eicosapentaenoate (EPA) for Depression.
In United KingdomThis study is recruiting in the United Kingdom. It is testing ethyl-eicosapentaenoate (ethyl-EPA) for schizophrenia.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on anxiety and currently lists participation information in Sweden.
In SwedenThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In DurhamThis study is recruiting. It focuses on depression and currently lists participation information in Canada.
In New WestminsterThis study is recruiting. It focuses on depression and currently lists participation information in Singapore.
In SingaporeThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.
In San DiegoThis study is recruiting. It focuses on anxiety and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on ADHD and currently lists participation information in Canada.
In MontrealThis study is recruiting in the United Kingdom. It focuses on anxiety.
In United KingdomThis study is recruiting. It focuses on ADHD and currently lists participation information in Japan.
In Japan